Can a new model forecast liver failure survival?

NCT ID NCT07548190

Ongoing Knowledge-focused Sponsor: The Second Affiliated Hospital of Chongqing Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at 2000 patients with acute-on-chronic liver failure caused by hepatitis B. Researchers will collect blood samples and medical data to build a model that predicts survival and complications at different time points. The goal is to give doctors a better way to estimate prognosis, but no new treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps doctors predict how liver failure patients will do, guiding treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. The model may not be accurate for all patients or in other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER FAILURE

Contacts and locations

Locations

Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University

Chongqing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.